Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07428083

Effect of Kinesio Taping Combined With Schroth Therapy in Young Adults With Idiopathic Scoliosis

Comparison of Schroth Therapy and Kinesiotaping in Lower Back and Back Pain in Young Adults With Idiopathic Scoliosis: A Double-Blind Placebo-Controlled Randomized Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
51 (estimated)
Sponsor
Fatih Sultan Mehmet Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

In this study, the effects of Kinesio Taping methods applied in combination with Schroth therapy on pain and functional capacity in young adults diagnosed with idiopathic scoliosis will be evaluated. This study is designed as a randomized controlled trial. Participants will be randomly assigned to one of three groups: Group 1: Schroth therapy combined with Kinesio Taping Group 2: Schroth therapy alone Group 3: Schroth therapy combined with sham Kinesio Taping Kinesio Taping will be applied for 4 weeks. The tape will remain in place for 5 consecutive days, followed by a 2-day rest period for the skin, and this cycle will be repeated throughout the intervention period. Schroth therapy will be administered 3 times per week for 4 weeks. Assessments will be conducted at baseline (Week 0), during treatment (Week 2), at the end of treatment (Week 4), and at follow-up (Week 8). The primary outcome measures will be pain intensity assessed by the Numeric Rating Scale (NRS) and functional disability assessed by the Oswestry Disability Index (ODI). Secondary outcome measures will include the Scoliosis Research Society-22 (SRS-22) questionnaire and the Patient Global Impression of Change (PGIC) scale.

Detailed description

The aim of this study is to evaluate the effects of Schroth therapy and the addition of Kinesio Taping on pain, functional capacity, and quality of life in young adults with idiopathic scoliosis who were diagnosed during adolescence and currently experience back pain. Adolescent idiopathic scoliosis (AIS) is a spinal deformity of unknown origin that develops during adolescence, with a worldwide prevalence of 1-3%. The current clinical gold standard for diagnosing scoliosis is the measurement of the Cobb angle on standing posteroanterior radiographs. The Cobb angle determines the severity classification of AIS; a Cobb angle of ≥40° indicates a severe deformity that may require surgical intervention, whereas lower angles are typically managed with non-surgical treatment approaches. Individuals aged 18-30 years are often described as having "young adult idiopathic scoliosis" (YAIS). Even if they received successful conservative treatment during adolescence, these individuals may present in adulthood with pain, progression of deformity, and cosmetic concerns. The development of symptoms in this age group increases the need for treatment, and evaluating the effectiveness of interventions applied during this period is clinically meaningful. The original Schroth exercises were developed in the early 20th century by Katharina Schroth. This exercise-based approach focuses on corrective breathing techniques and postural adjustments to address three-dimensional spinal deformities. Kinesio Taping (KT) is a conservative treatment method that has gained popularity in recent years for managing musculoskeletal conditions and controlling pain. This technique was first described by Kenzo Kase. Since an evidence-based treatment algorithm for managing back pain in patients with idiopathic scoliosis has not yet been clearly established, clinicians often select treatment methods based on preference. Common approaches include home exercise programs, physical therapy, pharmacological treatment (such as acetaminophen, non-steroidal anti-inflammatory drugs, muscle relaxants, or opioid analgesics), back school programs, and spinal manipulation. Both Schroth therapy and Kinesio Taping are non-invasive and conservative treatment methods commonly used in patients with idiopathic scoliosis. Although international studies have evaluated the effectiveness of Schroth therapy and Kinesio Taping separately, and some have explored combined applications, randomized controlled trials including a Schroth therapy group, a combined Schroth + Kinesio Taping group, and a sham taping control group in adult individuals are limited or absent in the national literature. The distinguishing aspect of this study is the controlled and comparative evaluation of the combination of Schroth therapy and Kinesio Taping, rather than assessing each method in isolation. Additionally, the inclusion of a sham taping group allows consideration of potential placebo effects. The findings of this study are expected to contribute to the evidence-based use of non-invasive treatment approaches in the management of idiopathic scoliosis

Conditions

Interventions

TypeNameDescription
OTHERSchroth TerapisiSchroth therapy is a scoliosis-specific exercise program designed to address three-dimensional spinal deformities. The intervention includes individualized corrective exercises, rotational angular breathing techniques, postural alignment training, trunk muscle stabilization, and muscular symmetry exercises. Sessions will be supervised by a certified physiotherapist three times per week for 4 weeks.
OTHERKinesio TapingKinesio Taping will be applied using elastic therapeutic tape with corrective tension techniques targeting spinal alignment and paraspinal muscle facilitation. The tape will remain in place for 5 consecutive days followed by a 2-day rest period. This cycle will be repeated throughout the 4-week intervention period.
OTHERSham Kinesio TapingSham Kinesio Taping will be applied using elastic therapeutic tape without therapeutic tension and without corrective technique. The tape will be placed in a non-corrective manner that does not aim to influence spinal alignment or muscle facilitation. The application schedule will be identical to the experimental taping group (5 days on, 2 days off for 4 weeks) to maintain participant blinding.

Timeline

Start date
2026-02-01
Primary completion
2026-06-01
Completion
2026-11-01
First posted
2026-02-23
Last updated
2026-03-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07428083. Inclusion in this directory is not an endorsement.